Shanghai, China

YuanQiang Li

This inventor holds 1 USPTO granted patent. Top assignee: Apotex Pharmachem Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: YuanQiang Li. Retrieved from https://idiyas.com/inventor/yuanqiang-li-v2php2uu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of YuanQiang Li in Pharmaceutical Chemistry

Introduction

YuanQiang Li is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of efficient processes for drug production. His work focuses on dopamine agonists, which are crucial in treating various medical conditions.

Latest Patents

YuanQiang Li holds 1 patent for his invention titled "Efficient process for the preparation of cabergoline and its intermediates." This invention relates to a new and efficient process for the production of dopamine agonists such as Cabergoline and its intermediates. This advancement is expected to enhance the manufacturing process and improve the availability of these important medications.

Career Highlights

YuanQiang Li is currently employed at Apotex Pharmachem Inc., where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset to his company and the industry at large.

Collaborations

YuanQiang Li has collaborated with several professionals in his field, including Zhi-Xian Wang and Murali Kondamreddy. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical processes.

Conclusion

YuanQiang Li's contributions to the field of pharmaceutical chemistry, particularly through his patent on cabergoline production, highlight his innovative spirit and dedication to improving drug manufacturing processes. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…